Tech Company Financing Transactions
Cell BioEngines Funding Round
Cell BioEngines secured a $2 million funding round on 7/22/2024. Investors included Empire State Development, Partnership Fund for New York City and SOSV.
Transaction Overview
Company Name
Announced On
7/22/2024
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
7 Penn Plaza, 9th Floor
New York, NY 10011
USA
New York, NY 10011
USA
Phone
Website
Email Address
Overview
Cell BioEngines, Inc., founded in Dec 2022, is a clinical-stage biotech company focused on developing allogeneic 'off-the-shelf' stem cell-derived therapies as 'drugs' for human disease treatment. The company leverages its proprietary platform technology using universal 'non-gene-modified' donor blood stem cells obtained from umbilical cord to produce clinical grade cells at scale.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ajay Vishwakarma
Chief Technical Officer
Alexey Bersenev
Vice President
Chris Anderson
Vice President
Brett Schrand
VP - General Counsel
Mark Joubert
Browse more venture capital transactions:
Prev: 7/21/2024: Gro Biosciences venture capital transaction
Next: 7/22/2024: Linx Security venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs